Lotus Eye Hospital (LOTUSEYE) | Stock Overview & Key Data
Lotus Eye Hospital Performance Comparison
Stock Range
Today's Range
Low: ₹120.30
High: ₹125.00
on October 3, 2025
52 Week Range
Low: ₹54.99
High: ₹139.20
on March 3, 2025
on September 3, 2025
All-Time High: ₹139.20 on September 3, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR2.5B
EPS
0.32
P/E Ratio (TTM)
379.19
Forward P/E
N/A
P/B Ratio
4.25
PEG Ratio
-28.44
Div. Yield
N/A
ROE
1.23%
Beta
0.423
Debt to Equity
5.72
Financial Highlights
Profitability
Gross Margin
49.70%
Operating Margin
4.86%
Profit Margin
1.32%
Returns and Earnings
Return on Assets (TTM)
1.06%
Return on Equity (TTM)
1.23%
EBITDA
INR50.1M
Net Income (TTM)
INR6.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR24.13
Quarterly Revenue Growth (YoY)
4.90%
Quarterly Earnings Growth (YoY)
-12.60%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Lotus Eye Hospital LOTUSEYE | 2.54B Small-cap | 1.79% | -7.67% | 68.44% | 73.42% | 73.89% | 56.59% | 53.89% | 294.60% |
| Apollo Hospitals APOLLOHOSP | 1.08T Large-cap | -0.81% | -3.70% | -1.53% | 11.66% | 1.08% | 9.98% | 69.53% | 227.15% |
| Max Healthcare MAXHEALTH | 1.05T Large-cap | -4.82% | -7.99% | -17.84% | -4.65% | -6.18% | 15.42% | 157.02% | 865.85% |
| Indraprastha Medical INDRAMEDCO | 42.43B Small-cap | 3.48% | -3.24% | -7.50% | 14.75% | -14.65% | 9.20% | 642.22% | 819.28% |
| Shalby SHALBY | 28.58B Small-cap | 7.74% | 35.22% | 42.91% | 25.35% | 15.19% | -1.79% | 99.07% | 178.07% |
| Dr. Agarwal's Eye DRAGARWQ | 23.46B Small-cap | 2.98% | 9.84% | 14.47% | 16.54% | -23.53% | 4.92% | 358.10% | 1,895.43% |
Ownership & Short Interest
Insider Ownership
65.17%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
28K
Average 90-Day Volume
189K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is LOTUSEYE's 52-week high and low?
- In the last 52 weeks, Lotus Eye Hospital reached a high of ₹139.20 (on September 3, 2025) and a low of ₹54.99 (on March 3, 2025).
- What is the market cap and P/E ratio for LOTUSEYE?
- Curious about Lotus Eye Hospital's size and valuation? Its market capitalization stands at 2.54B. When it comes to valuation, the P/E ratio (trailing twelve months) is 379.19, and the forward P/E (looking ahead) is N/A.
- Does LOTUSEYE pay dividends? If so, what's the yield?
- As for dividends, Lotus Eye Hospital isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Lotus Eye Hospital's main competitors or similar companies to consider before investing?
When looking at Lotus Eye Hospital, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Apollo Hospitals
APOLLOHOSP1.08T Healthcare Medical Care Facilities 9.98% 69.53% Max Healthcare
MAXHEALTH1.05T Healthcare Medical Care Facilities 15.42% 157.02% Indraprastha Medical
INDRAMEDCO42.43B Healthcare Medical Care Facilities 9.20% 642.22% Shalby
SHALBY28.58B Healthcare Medical Care Facilities -1.79% 99.07% Dr. Agarwal's Eye
DRAGARWQ23.46B Healthcare Medical Care Facilities 4.92% 358.10% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Lotus Eye Hospital and Institute Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Lotus Eye Hospital's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.23%, the Debt to Equity ratio from the most recent quarter is 5.72, and its Gross Profit Margin stands at 49.70%.
- What is the recent revenue and earnings growth for LOTUSEYE?
- Looking at Lotus Eye Hospital's growth, its revenue over the trailing twelve months (TTM) was INR502M. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.90%, and quarterly earnings saw a YoY growth of -12.60%.
- How much of LOTUSEYE stock is held by insiders and institutions?
- Wondering who owns Lotus Eye Hospital stock? Company insiders (like executives and directors) hold about 65.17% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.